About
Our Organisation

SANTHE is a Pan-African network of multidisciplinary experts collaborating – through pioneering basic, clinical, and translational research - to empower African scientists in the fight against HIV/AIDS and TB, associated morbidities, and emerging diseases like COVID-19.

Learn More
Our Scientists
Fellows

Researchers/Supervisors
Support Teams

SANTHE is a productive African-led scientific consortium which has a strong research and governance infrastructure in support of all partner institutions’ pursuit of intellectual and financial independence.

Learn More
Stories of Change View All

SANTHE Post-doctoral Alumnus leads expansion into Francophon...
Read More
Our Science
News & Opportunities
Resources

Search
Login
Pambazuko

Username or E-mail

Password

Only fill in if you are not human

Forgot your password?

About
About
- Our Organisation
- Our Scientists
  - Fellows
  - Researchers/Supervisors
- Support Teams
- Stories of Change
Our Science
Our Science
- Projects
- Publications
News & Opportunities
News & Opportunities
- News
- Events
- Funding
Resources
Resources
Login Pambazuko

Home Publications The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana

Publications

T

The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana

Medicine

View Publication

Share on social
Facebook
Twitter
LinkedIn

Authors

Maseng, M.J., Tawe, L., Thami, P.K., Moyo, S., Kasvosve, I., Novitsky, V., Essex, M., Russo, G., Gaseitsiwe, S., Paganotti, G.M.

About
Contact
Sitemap

SANTHE is an Africa Health Research Institute (AHRI) flagship programme funded by the Science for Africa Foundation through the DELTAS Africa programme; the Bill & Melinda Gates Foundation; Gilead Sciences Inc.; and the Ragon Institute of Mass General, MIT, and Harvard.

Copyright 2016 by SANTHE. All Rights Reserved.

Privacy
Terms and Conditions
Cookie Preference